These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials. Blauvelt A; Rosmarin D; Bieber T; Simpson EL; Bagel J; Worm M; Deleuran M; Katoh N; Kawashima M; Shumel B; Chen Z; Rossi AB; Hultsch T; Ardeleanu M Br J Dermatol; 2019 Jul; 181(1):196-197. PubMed ID: 30719707 [No Abstract] [Full Text] [Related]
25. Dupilumab for off-label treatment of moderate to severe childhood atopic dermatitis. Jorge E; Clark J Cutis; 2018 Sep; 102(3):201-204. PubMed ID: 30372706 [TBL] [Abstract][Full Text] [Related]
26. Atopic dermatitis treatment: Current state of the art and emerging therapies. Silverberg JI Allergy Asthma Proc; 2017 Jul; 38(4):243-249. PubMed ID: 28668106 [TBL] [Abstract][Full Text] [Related]
28. New alcohol flushing in a patient with atopic dermatitis under therapy with dupilumab. Herz S; Petri M; Sondermann W Dermatol Ther; 2019 Jan; 32(1):e12762. PubMed ID: 30288874 [No Abstract] [Full Text] [Related]
29. Naphthalene in the treatment of patients with atopic dermatitis. Smeh-Skrbin A; Dobrić I; Krnjević-Pezić G; Vrzogić P Acta Dermatovenerol Croat; 2007; 15(1):15-9. PubMed ID: 17433174 [TBL] [Abstract][Full Text] [Related]
30. Dupilumab for Atopic Dermatitis, a Possible Risk Factor of Juvenile Ischemic Stroke: A Case Report. Iwase R; Ishiguro T; Fujita K; Ishibashi S; Yokota T J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104763. PubMed ID: 32265139 [TBL] [Abstract][Full Text] [Related]
31. Atopic dermatitis: recent insight on pathogenesis and novel therapeutic target. D'Auria E; Banderali G; Barberi S; Gualandri L; Pietra B; Riva E; Cerri A Asian Pac J Allergy Immunol; 2016 Jun; 34(2):98-108. PubMed ID: 27007830 [TBL] [Abstract][Full Text] [Related]
32. New and emerging therapies for paediatric atopic dermatitis. Vakharia PP; Silverberg JI Lancet Child Adolesc Health; 2019 May; 3(5):343-353. PubMed ID: 30904349 [TBL] [Abstract][Full Text] [Related]
33. Clinical and immunopathologic findings during treatment of recalcitrant atopic eczema with efalizumab. Hassan AS; Kaelin U; Braathen LR; Yawalkar N J Am Acad Dermatol; 2007 Feb; 56(2):217-21. PubMed ID: 17113187 [TBL] [Abstract][Full Text] [Related]
35. Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials. Fleming P; Drucker AM J Am Acad Dermatol; 2018 Jan; 78(1):62-69.e1. PubMed ID: 28987493 [TBL] [Abstract][Full Text] [Related]
36. Dupilumab: A review of its use in the treatment of atopic dermatitis. Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919 [TBL] [Abstract][Full Text] [Related]
37. A Review of Cutaneous Microdialysis of Inflammatory Dermatoses. Rea H; Kirby B Acta Derm Venereol; 2019 Oct; 99(11):945-952. PubMed ID: 31120543 [TBL] [Abstract][Full Text] [Related]